stockrow
Friday 6 November 2026
Export CDIO’s income statement to Excel — free account
Cardio Diagnostics Holdings, Inc.
CDIO Healthcare Biotechnology
Cardio Diagnostics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14,800.00, down 57.6% from fiscal 2024.
- Revenue
- +23.8%
- EPS
- +47.4%
- Free cash flow
- +2.59%
Quarter to September 2026, against a year earlier
1.65
0.03
−1.79%
Follow CDIO
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 3 | 3 | — |
+8 more TTM periods Free account |
| (93.55%) | (75.44%) | (65.59%) | (78.62%) | ||
| (87.24%) | (70.62%) | (60.91%) | (70.70%) | ||
ROIC |
(227.98%) | (219.40%) | (227.16%) | (217.55%) | |
Return on Tangible Assets |
(138.81%) | (100.86%) | (84.08%) | (108.02%) | |
Average Days of Receivables |
84.74 | 97.50 | 93.98 | 198.42 | |
Free Cash Flow per Share |
0.00 | (1.97) | (2.14) | (3.38) | |
Free Cash Flow |
(5.78) | (5.82) | (6.07) | (5.91) | |
Capital Expenditures |
— | (0.16) | (0.18) | (0.19) | |
| Other line items | |||||
Cash ROIC |
(59.85%) | (44.76%) | (38.00%) | (48.94%) | |
Accounts Receivable Turnover |
2.07 | 1.74 | 2.40 | 1.12 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 5,582.88% | 4,616.77% | 5,760.40% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 39,817.12% | 35,793.41% | 38,876.51% | |
Share Based Compensation of Revenue |
637.27% | 670.55% | 624.55% | 739.60% | |
Interest Coverage |
(568.44) | (529.32) | (491.73) | (438.11) | |
Operating CF/Net income |
0.89 | 0.87 | 0.89 | 0.88 | |
Depreciation/Fixed assets |
0.67 | 0.61 | 0.56 | 0.57 | |
Capex/Depreciation |
0.00 | (0.44) | (0.50) | (0.47) | |
Revenue per Share |
0.00 | 0.00 | 0.01 | 0.01 | |
Operating CF per Share |
0.00 | (1.91) | (2.07) | (3.27) | |
Capex per Share |
— | (0.06) | (0.06) | (0.11) | |
Capex to Sales |
0.00 | 11.27 | 10.98 | 12.57 |
Columns are period end dates · fundamentals updated 6 Nov 2026